Detalhe da pesquisa
1.
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain.
Mol Ther
; 32(2): 503-526, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38155568
2.
Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion.
J Infect Dis
; 225(7): 1118-1123, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34940844
3.
Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study.
Crit Care Med
; 50(1): 81-92, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34259446
4.
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Biol Blood Marrow Transplant
; 25(4): 625-638, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30592986
5.
Effects of starting cellular material composition on chimeric antigen receptor T-cell expansion and characteristics.
Transfusion
; 59(5): 1755-1764, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30973976
6.
Toxicities of chimeric antigen receptor T cells: recognition and management.
Blood
; 127(26): 3321-30, 2016 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27207799
7.
Discordant bone marrow involvement in non-Hodgkin lymphoma.
Blood
; 127(8): 965-70, 2016 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26679865
8.
T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.
Blood
; 128(13): 1688-700, 2016 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27412889
9.
Current understanding and management of CAR T cell-associated toxicities.
Nat Rev Clin Oncol
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38769449
10.
Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trial.
Blood Adv
; 8(3): 802-814, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37939262
11.
Constitutional telomerase mutations are genetic risk factors for cirrhosis.
Hepatology
; 53(5): 1600-7, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21520173
12.
Acute and delayed cytopenias following CAR T-cell therapy: an investigation of risk factors and mechanisms.
Leuk Lymphoma
; 63(8): 1849-1860, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35389319
13.
The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes.
Blood Adv
; 6(23): 6040-6050, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35939781
14.
CAR T-Cell Therapy in Hematologic Malignancies: Clinical Role, Toxicity, and Unanswered Questions.
Am Soc Clin Oncol Educ Book
; 41: 1-20, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33989023
15.
Year-long COVID-19 infection reveals within-host evolution of SARS-CoV-2 in a patient with B cell depletion.
medRxiv
; 2021 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34642697
16.
Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.
Nat Med
; 26(5): 803, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32291416
17.
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.
Nat Med
; 26(2): 270-280, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959992
18.
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events.
J Immunother Cancer
; 8(2)2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33335028
19.
The chimeric antigen receptor-intensive care unit (CAR-ICU) initiative: Surveying intensive care unit practices in the management of CAR T-cell associated toxicities.
J Crit Care
; 58: 58-64, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32361219
20.
Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management.
Blood Rev
; 34: 45-55, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30528964